Answers are grounded in this paper and cite their sources.
Bioinformatics analysis reveals candidate biomarkers in glioblastoma, suggesting new treatment strategies.
This poster presents a bioinformatics analysis of differential gene expression between glioblastoma and normal brain tissue using GEO dataset GSE196695. The study identifies significantly differentially expressed genes (DEGs) and examines their involvement in key biological processes, including cell proliferation, extracellular matrix (ECM) organization, and growth factor–related signaling pathways. The findings highlight potential biomarkers and suggest therapeutic targets, while also revealing parallels between tumor progression and normal wound healing and tissue regeneration mechanisms.
No takes yet. Share an insight, caveat, or question.
Gabriel Muraszczuk (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: